Sponsored by 
Date: Tuesday 16 June 2026
Time: 15:00 - 16:00 BST
What you'll learn
By attending, you'll gain:
- Regulatory complexities of qualifying novel healthcare products
- Contrasting viewpoints across the globe
- Proven strategies for reaching alignment on regulatory pathways
- Practical recommendations to avoid regulatory pitfalls and scrutiny
Who should attend
Regulatory Professionals and Senior Leaders responsible for the development of novel drugs, devices, combination products and healthcare products.
Webinar host & presenters
|
Presenter: Dr. Tido Eger
Senior Consultant, Granzer Regulatory Consulting & Services GmbH
Tido Eger is an experienced life sciences consultant with more than 20 years’ experience, specialising in medical devices, digital health, and combination products, with deep expertise in regulatory affairs, quality management, and technology strategy. His work focuses on Software as a Medical Device (SaMD), AI-enabled software, and drug–device combinations in regulated environments. Tido has held senior QARA leadership roles in industry and currently advises clients across Europe, the UK, and the US at Granzer Regulatory Consulting. He holds a PhD from the University of Cambridge.
|
|
Presenter: Dr. Uwe Gosslar
Principal Consultant, Granzer Regulatory Consulting & Services GmbH
Uwe Goßlar started his industry career in the biotech business in 2000 where he held various positions. In 2008 he joined Sandoz GmbH. He was globally responsible for all medical device aspects of Novartis/Sandoz biosimilar projects. He was involved in successful development and certification/ licensing of pen- and autoinjectors as well as MA procedures for drug-device combination products incl. pre-filled pens and syringes. Dr Goßlar joined Granzer Regulatory Consulting & Services in July 2019 as consultant for medical device development and regulatory affairs.
|
 |
Presenter: Dr. Heather Johnson
Senior Consultant, Granzer Regulatory Consulting & Services GmbH
Heather Johnson (PhD, RAC) has over 25 years’ regulatory experience in drug-device combinations, borderline products and companion diagnostic devices. After gaining a PhD in chemistry, she has worked on oral pharmaceutical products, resorbable and drug-eluting orthopaedic devices and oncology companion diagnostic devices. She has demonstrated success in global registrations, lifecycle management and developing MDR implementation strategies across a large multinational corporation. Heather now leverages her wide experience to support Granzer’s clients with regulatory strategies and submissions for novel devices, IVDs, combination products and combined clinical trials.
|
| |
|
Pricing
| Standard webinar registration fees |
| Webinar Registration Type |
Price (GBP) |
Standard Price
TOPRA Member |
FREE |
Standard Price
Non-member |
FREE |
Invest in your expertise this year and save with TOPRA membership
Advance your regulatory knowledge and broaden your professional expertise while making your development budget go further.
Not yet a TOPRA member? Join today and benefit from ongoing savings that make membership a smart investment in your long-term growth. As a member, you’ll gain more than just discounts: you’ll access exclusive learning opportunities, expert insights, and a network of professionals shaping the future of regulatory affairs. Whether you take one course or all three, TOPRA membership helps you gain more from your development while spending less.
Join today